We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DNA market cap is 456.84M. The company's latest EPS is USD -16.0659 and P/E is -0.51.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 80.57M | 55.43M | 34.76M | 37.94M | 56.21M |
| Operating Income | -185.67M | -190.18M | -179.24M | -178M | -222.95M |
| Net Income | -173.32M | -302.89M | -211.69M | -165.91M | -217.18M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 313.84M | 477.71M | 251.46M |
| Operating Income | -5k | -1.91B | -2.25B | -770.83M |
| Net Income | -5k | -1.83B | -2.1B | -892.87M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 2.29B | 2.03B | 1.67B | 1.58B | 1.63B |
| Total Liabilities | 788.41M | 773.71M | 568.19M | 594.49M | 792.18M |
| Total Equity | 1.5B | 1.25B | 1.1B | 987.27M | 833.07M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.25M | 2.07B | 2.54B | 1.67B |
| Total Liabilities | 1.23M | 503.61M | 803.04M | 568.19M |
| Total Equity | 20k | 1.57B | 1.74B | 1.1B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -164.12M | -237.67M | -295.5M | -89.26M | -173.65M |
| Investing | -30.64M | -34.02M | -80.69M | -12.11M | -38.95M |
| Financing | -2.27M | -2.58M | -3.22M | -845k | -1.07M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -253.82M | -252.2M | -295.5M |
| Investing | N/A | -73.26M | -67.39M | -80.69M |
| Financing | N/A | 1.53B | 95.34M | -3.22M |
| Market Cap | 456.84M |
| Price to Earnings Ratio | -0.51 |
| Price to Sales Ratio | 1.83 |
| Price to Cash Ratio | 0.49 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 55.58M |
| Average Volume (1 week) | 2.83M |
| Average Volume (1 Month) | 1.96M |
| 52 Week Change | 18,372.13% |
| 52 Week High | 9.33 |
| 52 Week Low | 0.00525 |
| Spread (Intraday) | 0.02 (0.24%) |
| Company Name | Ginkgo Bioworks Holdings Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ginkgobioworks.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
